THE POTENTIAL IMPROVEMENT OF THROMBOLYTIC THERAPY BY TARGETING WITH BISPECIFIC MONOCLONAL-ANTIBODIES - WHY THEY ARE USED AND HOW THEY ARE MADE

被引:6
作者
BOS, R
NIEUWENHUIZEN, W
机构
[1] IVVO-TNO, Gaubius Laboratory, Leiden, 2300 AK
关键词
BISPECIFIC MONOCLONAL ANTIBODIES; DRUGS TARGETING; SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR; THROMBOLYTIC THERAPY; TISSUE-TYPE PLASMINOGEN ACTIVATOR;
D O I
10.1007/BF02171051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The generation of the proteolytic enzyme plasmin from its inactive precursor plasminogen, mediated by so called plasminogen activators, is the essential step in thrombolytic therapy. Plasmin is responsible for the degradation of the insoluble fibrin, the major component of a thrombus, to soluble fibrin degradation products. So far, the use of the more recently developed thrombolytic agents single-chain urokinase-type plasminogen activator (scu-PA) and tissue-type plasminogen activator (t-PA) were disappointing, mainly due to some of their negative properties in vivo, i.e., rapid inhibition and/or hepatic clearance. Besides some background information on the haemostatic balance; t-PA and scu-PA structure; and mechanisms of action, we here review some reported attempts to improve on these agents for thrombolytic therapy following various strategies. One of the more potential strategies, antibody-targeted thrombolytic therapy using bispecific monoclonal antibodies, is discussed somewhat more extensively, as are the several procedures that can befollowed for bispecific antibody preparation.
引用
收藏
页码:187 / 199
页数:13
相关论文
共 86 条
[1]  
AHERN TJ, 1990, J BIOL CHEM, V265, P5540
[2]   CONSTRUCTION OF A FUSION GENE THAT CONFERS RESISTANCE AGAINST HYGROMYCIN-B TO MAMMALIAN-CELLS IN CULTURE [J].
BERNARD, HU ;
KRAMMER, G ;
ROWEKAMP, WG .
EXPERIMENTAL CELL RESEARCH, 1985, 158 (01) :237-243
[3]  
BODE C, 1989, J BIOL CHEM, V264, P944
[4]   CONJUGATION TO ANTIFIBRIN FAB' ENHANCES FIBRINOLYTIC POTENCY OF SINGLE-CHAIN UROKINASE PLASMINOGEN-ACTIVATOR [J].
BODE, C ;
RUNGE, MS ;
SCHONERMARK, S ;
EBERLE, T ;
NEWELL, JB ;
KUBLER, W ;
HABER, E .
CIRCULATION, 1990, 81 (06) :1974-1980
[5]   ENHANCED TRANSFECTION OF A BACTERIAL PLASMID INTO HYBRIDOMA CELLS BY ELECTROPORATION - APPLICATION FOR THE SELECTION OF HYBRID HYBRIDOMA (QUADROMA) CELL-LINES [J].
BOS, R ;
NIEUWENHUIZEN, W .
HYBRIDOMA, 1992, 11 (01) :41-51
[6]  
BOS R, 1991, THROMB HAEMOSTASIS, V65, P779
[7]  
BOS R, IN PRESS FIBRINOLYSI
[8]  
BOS R, 1990, CLONE CLIN, P167
[9]  
BRANSCOMB EE, 1990, THROMB HAEMOSTASIS, V64, P260
[10]   PREPARATION OF BISPECIFIC ANTIBODIES BY CHEMICAL RECOMBINATION OF MONOCLONAL IMMUNOGLOBULIN-G1 FRAGMENTS [J].
BRENNAN, M ;
DAVISON, PF ;
PAULUS, H .
SCIENCE, 1985, 229 (4708) :81-83